Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective study

被引:0
作者
Majid Alfadhel
Muhammad Umair
Malak A. Alghamdi
Khalid Al Fakeeh
Abdullah T. Al Qahtani
Afrah Farahat
Mohamed A. Shalaby
Jameela A. Kari
Rupesh Raina
Pierre Cochat
Khalid A. Alhasan
机构
[1] Ministry of National Guard Health Affairs (MNG-HA),Genetics and Precision Medicine Department (GPM), King Abdullah Specialized Children’s Hospital, King Abdulaziz Medical City
[2] King Saud Bin Abdulaziz University for Health Sciences(KSAU-HS),Medical Genomic Research Department, King Abdullah International Medical Research Center(KAIMRC)
[3] Ministry of National Guard Health Affairs (MNG-HA),Medical Genetic Division, Department of Pediatrics, College of Medicine
[4] King Saud University,Nephrology Division, Department of Pediatrics, King Abdullah International Medical Research Center (KAIMRC)
[5] King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS),Division of Nephrology, Department of Pediatrics
[6] Ministry of National Guard Health Affairs (MNG-HA),Pediatric Nephrology Center of Excellence, King Abdulaziz University Hospital, Department of Pediatrics
[7] King Saud University Medical City,Department of Nephrology
[8] King Saud University,Centre de Référence Des Maladies Rénales Rares Néphrogones
[9] King Abdulaziz University,Division of Nephrology, Department of Pediatrics, College of Medicine
[10] Cleveland Clinic Akron General and Akron Childrens Hospital,Division of Pediatric Kidney Transplant, Organ Transplant Center of Excellence
[11] Hospices Civils de Lyon & Université Claude-Bernard Lyon 1,undefined
[12] King Saud University,undefined
[13] King Faisal Specialist Hospital and Research Center,undefined
来源
Pediatric Nephrology | 2023年 / 38卷
关键词
Saudi Arabia; Primary hyperoxaluria; Nephrocalcinosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1801 / 1810
页数:9
相关论文
共 264 条
  • [1] Hoppe B(2012)An update on primary hyperoxaluria Nat Rev Nephrol 8 467-475
  • [2] Martin-Higueras C(2017)Molecular therapy of primary hyperoxaluria J Inherit Metab Dis 40 481-489
  • [3] Torres A(2019)Molecular basis of primary hyperoxaluria: clues to innovative treatments Urolithiasis 47 67-78
  • [4] Salido E(2012)Primary hyperoxalurias: disorders of glyoxylate detoxification Biochim Biophys Acta 1822 1453-1464
  • [5] Dindo M(2009)Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene Hum Mutat 30 910-917
  • [6] Conter C(2003)Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2 Hum Mutat 22 497-436
  • [7] Oppici E(2016)Primary hyperoxaluria: a review Nephrol Ther 12 431-376
  • [8] Ceccarelli V(2012)Extreme intrafamilial variability of Saudi brothers with primary hyperoxaluria type 1 Ther Clin Risk Manag 8 373-e44
  • [9] Marinucci L(2004)Molecular aetiology of primary hyperoxaluria type 1 Nephron Exp Nephrol 98 e39-1081
  • [10] Cellini B(2006)Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol 21 1075-455